Hybio Pharmaceutical Market Cap

Hybio Pharmaceutical has a market cap or net worth of 16.69 billion as of December 5, 2025. Its market cap has increased by 50.84% in one year.

Market Cap

16.69B

Enterprise Value

18.50B

Revenue

898.10M

Ranking

n/a

PE Ratio

n/a

Stock Price

18.90

Market Cap Chart

Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 16.69B, an increase of 469.74%. That is a compound annual growth rate of 12.59%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	16.69B	46.63%
Dec 31, 2024	11.38B	-5.08%
Dec 29, 2023	11.99B	-22.75%
Dec 30, 2022	15.53B	39.41%
Dec 31, 2021	11.14B	88.22%
Dec 31, 2020	5.92B	14.66%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	407.00B
WuXi AppTec	267.43B
Shenzhen Mindray Bio-Medical Electronics	241.88B
Sichuan Biokin Pharmaceutical	150.71B
Shanghai United Imaging Healthcare	105.68B
Aier Eye Hospital Group	104.39B
Zhangzhou Pientzehuang Pharmaceutical.,	101.81B
Yunnan Baiyao Group Co.,Ltd	99.44B

Market Cap Rankings